This study reports on the outcomes of TSS in 86 patients with invasive corticotroph adenomas who underwent at the PUMCH between 2000 and 2019. To our knowledge, this is one of the largest series on invasive corticotroph adenomas published till now. This study demonstrated that the immediate remission of the surgical approach and the long-term outcome after adjuvant therapies for patients with invasive corticotroph adenomas are unsatisfactory. Additionally, invasion evaluated using Knosp grade based on preoperative MRI not always accurately predict intraoperatively observed invasiveness. Moreover, extent of tumor resection and number of operations significantly affected the surgical outcome of TSS for invasive corticotroph adenomas. However, the Knosp grade, tumor size, and technical factor is not associated with the surgical outcome.
Preoperative MRI-based Knosp grade classifications play a crucial role in diagnosis of cavernous sinus invasion (CSI) of corticotroph adenomas. However, radiological results do not always discriminate between compression/extension and invasion of CS. In this study, only 84.0 % (42 of 50) of the patients with MRI-based Knosp grade 3 was intraoperatively identified with CSI, and other 8 patients with Knosp grade 3 adenomas did not have CSI at surgery. Further, 5.4% (4 of 74) patients with MRI-based Knosp grade 2 adenomas were found invasion during surgery. These findings are consistent with previous studies(15, 16). Dickerman and colleagues (17) demonstrated that dural invasion was directly observed at surgery and was confirmed histologically in 62% of the patients with no adenomas were interpreted based on preoperative MRI. Lonser also reported that preoperative MRI accurately predicted dural invasion in only 4 patients (22%) with CSI (18). Other previous studies also indicated that Knosp classification does not predict accurately the invasion of the Knosp grade 0–2 adenomas, thus their application in the prediction of invasion among microadenomas is limited (19). A recent Meta-Analysis also reported that the prevalence of CSI radiographically (43%) was much higher than that (18%) intraoperatively, and the radiologic criteria of Knosp 3–4 had the highest correlation with intraoperative CSI (20). Therefore, although MRI-based Knosp grade can reliably define the degrees of CSI in Knosp 3–4 larger tumors, it is often unreliable to define the absence of dural invasion in Knosp 0–2 microadenomas. To define more accurately invasion beyond the lateral tangential line between ICA segments respectively, Knosp updated the original grading system of invasion in PAs by establishing the subtypes of grade 3a and 3b PAs in 2015(15). However, up to 80% of CD patients present with a microadenoma, and there is no reliable grading system for microadenomas that predicts accurately CSI. Thus, more reliable grading systems of invasion for corticotroph adenomas are need.
For invasive corticotroph adenomas, complete surgical resection of tumor is difficult. Thus, lower remission rates of TSS have been reported in the patients with invasive corticotroph adenomas. However, 48.8 % of patients with invasive corticotroph adenomas in our center achieved remission after TSS, which was higher than that reported in previous studies (7, 21). The main reasons for the higher remission rate may include the experienced neurosurgeon, intraoperative multiple techniques assistance and aggressive surgical procedure.
Surgery for invasive corticotroph adenomas has always been a challenge because of the highly complex anatomy of the CS and difficult in CS dissection. Thus, experienced neurosurgeon is essential to achieve complete tumor resection, biochemical remission, and avoid perioperative complications. In our center, almost all the surgery for CD patients were performed by Pro. Renzhi Wang and Ming Feng, who had experience with more than one thousand pituitary surgeries as previously described(22). Each year, more than one hundred of CD patients undergo pituitary surgery in our center, and a large part of them are invasive macroadenomas and recurrent CD(23). The number of surgical patients with CD may be one of the largest centers. Therefore, large-scale surgical patients with CD have accumulated rich surgical experience in management of patients with invasive corticotroph adenomas. Unfortunately, even in the hands of experienced surgeons, only about half of patients with invasive corticotroph adenomas could achieve remission after TSS. There are several studies also found that biochemical remission rate is related to the number of years of neurosurgical experience. Yap and colleagues reported that the first decade of neurosurgery experience was associated with lower remission rates than that with the second and third decade of neurosurgery experience(24). A recent meta-analysis also demonstrated that the possible association of neurosurgeons’ experience with remission rates in CD patients (25). Therefore, neurosurgical experience may be one of main reasons for the higher remission rate of TSS in patients with invasive corticotroph adenomas.
Application of multiple techniques assistance maybe another important factor for higher remission rate of TSS in patients with invasive corticotroph adenomas. In this study, multiple techniques including neuronavigation and intraoperative Doppler ultrasonography were used intraoperatively for surgical assistance in most patients, which resulted in maximum tumor removal and a relatively low rate of perioperative complications. For larger and recurrent invasive corticotroph adenomas, neuronavigation and Doppler ultrasonography was used to determine the exact location of the ICA. These techniques can provide references for locating some important structures including the ICA, brainstem, and optic canal in real time during surgery(26). Precisely location these structures can prevent to injuries them, thereby decrease the frequency of perioperative complications. T. J. Owen also reported that using the neuronavigation system for localization the rostral and caudal margins of the pituitary fossa during TSS may decrease morbidity and surgical time (27). Doppler ultrasonography also has been shown to determine the exact location of the ICA and whether it exist an aneurysm, thereby avoid to injury ICA the during surgery (28). Therefore, these multiple techniques assistance used in surgery facilitate tumor resection, the operation safe and decrease perioperative complications in patients with corticotroph adenomas.
In our center, aggressive procedure was used to pursue a maximum safe removal of tumor. During the surgery, in order to accurately assess the dural invasion and to remove the tumor maximally, it is critical to widely expose of the anterior and inferior sella dura, even the medial dural wall of the cavernous sinuses. Thus, endoscopic extended transsphenoidal surgery was used for most lager invasive corticotroph adenomas, which provide direct visualization for resection of the tumors invading the CS and suprasellar (28). Recently, the incision of the CS wall also has been performed for PAs invading the CS, which resulted in a higher GTR rate(12). Therefore, rich surgical experience, wide exposure by endoscopic extended transsphenoidal surgery and incision of the CS, and intraoperative assistance of combined neuronavigation and intraoperative Doppler ultrasonography are the main reasons for the higher remission rate in our center.
Identification of the factors affecting surgical outcomes is very is important for predicting the prognosis of patients with invasive corticotroph adenomas. In this study, we found that the remission rate (75%) in patients with Knosp grade 2 adenomas is higher than that in patients with Knosp grade 3 adenomas (55.6%) and Knosp grade 4 adenomas (41.3%), but it did not reach the statistical significance. This result indicated that the MRI-based Knosp grade classifications was not related to immediate remission in invasive corticotroph adenomas, which is consistent with the results of most previous studies. Similarly, Wagenmakers (6) reported that the remission was achieved in 50.0% of patients with Knosp grade 2 invasion, 37.5 % of patients with Knosp grade 3 invasion, and 33.3 % patients with Knosp grade 4 invasion, respectively. However, another study by Witek showed that the immediate postoperative remission depended on invasiveness based on Knosp grades 3 and 4 for macroadenomas (29). However, only 4 patients with Knosp grade 2 adenomas were included in the present study, and more large-scale studies are need to further verify this conclusion.
Whether the adenoma size affect the surgical remission in patients with corticotroph adenoma is remaining controversial. In our study, patients with invasive microadenomas had higher immediate remission rates than that in patients with invasive macroadenomas and invasive giant adenomas, however, it does not reach statistical significance. This is consistent with the results from some previous studies. Starke reported that there was no significant difference in remission among patients with microadenomas and macroadenomas(31). Feng also reported that CD patients with macroadenomas and microadenomas had similar remission rate after TSS(11). On the contrary, a few studies have opposite conclusions, Blevins(32) indicated that CS invasion and the presence of a tumor diameter ≥ 2.0 cm were characteristics associated with an increased likelihood of residual disease after surgery. Other studies also demonstrated an inverse correlation between remission rates and tumor size in patients with CD (33, 34). However, most of previous studies reported that the effect of tumor diameter on remission rate in patients with CD, but not patients with invasive corticotroph adenoma. Therefore, more studies on potential factors predicting surgical outcomes in patients with invasive corticotroph adenomas are needed.
In this study, we found that the repeated TSS for invasive corticotroph adenomas has been shown significant lower remission rates compared with the first TSS. The main reasons for this result maybe that the destruction of the original anatomy and scar formation within the recurrent tumor. These factors make the surgery more difficult and dangerous. Valderrábano and colleagues (35) also demonstrated that the repeat TSS for CD is associated to a lower remission rate and a higher risk of recurrence, which is consistent to our results. However, the large-scale clinical study on results of repeat TSS for invasive corticotroph adenomas is limited, and further studies are needed.
Depending on neurosurgeon’s preference, TSS for invasive corticotroph adenomas could be performed by microscopic or endoscopic approach. Compared with microscopic approach, the endoscopic approach provides a broader surgical view of pituitary region, including lateral edges of the sella and cavernous sinuses. However, in this study, no significant difference was found in the remission rates among the patients with invasive corticotroph adenomas who underwent microscopic TSS and endoscopic TSS. The microscopic and endoscopic techniques were used in combination for subset of patients with invasive corticotroph adenomas, which might explain why endoscopic versus microscopic technique yielded the similar remission rate in our center. This result in accordance with one recent meta-analysis, which indicated that comparisons of remission rates by endoscopic versus microscopic technique yielded the same results(36). However, another meta-analysis demonstrated that the endoscopic TSS reaches comparable results for microadenomas, and probably better results for macroadenomas than microscopic TSS for CD patients (37). To date, the data about comparisons of remission rates by endoscopic versus microscopic technique in invasive corticotroph adenomas is limited, more studies on comparison of the two techniques in patients with invasive corticotroph adenomas at the same institution are needed.
It is difficult to manage patients with persistent or recurrent invasive corticotroph adenomas. Therapy options include radiation therapy, repeated TSS, medical therapy, and as a final step bilateral adrenalectomy. These treatments have their own advantages and disadvantages, however, there is no consensus on which treatment is preferable. In our center, an individual-based comprehensive treatment was discussed by a multidisciplinary team (MDT) with collaborating experts. However, even if comprehensive treatments were used, the prognosis of these patients is still poor, and more effective treatment are need.